Botox Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Mexico, Brazil, Germany, Japan - Size and Forecast 2024-2028

Published: Jan 2024 Pages: 154 SKU: IRTNTR71048

Botox Market Forecast  2024-2028

The botox market size is forecast to increase by USD 4.58 billion, at a CAGR of 9.66% between 2023 and 2028.

There has been a rising demand for minimally invasive procedures as they are associated with less pain, fewer complications, and shorter hospital stays. In addition, the advancements in technology and developments of innovative techniques and equipment allow more precise, effective, and less invasive procedures. Moreover, advancements in minimally invasive procedures include laser technology, injectables such as Botox and dermal fillers, and the use of small incisions. Hence, such factors are positively impacting the market.

Technavio has segmented the market into  Application, End-user, and Geography

  • The application segment is classified into aesthetic and medical
  • The end-user segment is classified into hospitals, dermatology clinics, and others
  • The geography segment includes key regions such as North America, Europe, Asia, and Rest of World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018 - 2022, besides analyzing the current market scenario.

What will be the Size of the Botox Market During the Forecast Period?

To learn more about this report, Download Report Sample

Market Segmentation by Application, End-user, and Geography Analysis

Application Analysis

Aesthetic

The aesthetic segment is estimated to witness significant growth during the forecast period. The aesthetic segment of the global market is expected to achieve steady growth fuelled by the increase in awareness about the various types of procedures and innovations emerging in the aesthetic segment. In addition, annual reports by global medical aesthetic organizations, such as the International Society of Aesthetic Plastic Surgery (ISAPS) and the American Society for Aesthetic Plastic Surgery (ASAPS), have found a global increase in the number of aesthetic procedures conducted across the world. 

Get a glance at the market contribution of various segments Download PDF Sample

The aesthetic segment was the largest segment and was valued at USD 4.22 billion in 2018. Moreover, the growing geriatric population (people aged 65 years or above) is also a key factor driving the growth of the aesthetic segment in the (botulinum toxin) market. In addition, older adults have become more concerned about their appearance and are readily opting for these skin procedures. Furthermore, the demand for aesthetic medicines has also surged among men. The ease of treatment procedures and effective and timely results are the key factors that are driving the demand among men for medical aesthetic procedures. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.

End-user Analysis

Hospitals

It offers several benefits to hospitals and clinics across multiple levels and roles, including improved patient care and satisfaction, enhanced operations at point of care (POC), and facilitating cost savings by strengthening the operational bottom line. In addition, in 2023, the hospitals were the major revenue contributors to the growth of the (botulinum toxin) market owing to factors such as the increasing number of surgeries and the presence of skilled professionals. Moreover, governments of countries such as the UK are taking effective measures to make medical aesthetic products accessible to people; hence, they promote the usage of Botox in hospitals. Furthermore, the increasing growth of Tier-1 hospitals has led to an increase in the adoption of medical aesthetic products in POC settings. Hence, such factors are fuelling the growth of this segment which, in turn, drives the market growth during the forecast period.

Dermatology clinics

In dermatology clinics is utilized for different cosmetic and medical purposes, due to its ability to temporarily relax muscles and reduce certain skin concerns. In addition, it is commonly used on the upper half of the face to target horizontal forehead lines, glabellar frown lines, and lateral canthal lines (Crows feet). Moreover,  dermatologists may recommend injections to prevent the formation of new wrinkles by relaxing muscles that contribute to premature aging, especially in areas prone to wrinkling due to facial expressions. Furthermore, the increase in demand for cosmetic procedures, including injections, dermal fillers, laser treatments, and chemical peels, has led to an increased demand for dermatology services. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 51% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. Factors such as rapid advances in technology, increasing awareness about aesthetic procedures, increasing demand for minimally invasive techniques, and growth in the number of older adults are some of the factors fuelling the growth of this botulinum toxin market in North America. In addition, the population aged 60 years and above is on the rise in North America. Moreover, people of this age group are susceptible to aging signs, such as wrinkles, scars, and acne. In addition, to treat these skin conditions, some individuals are increasingly opting for cosmetic surgeries. Furthermore, this has increased the demand for cosmetic surgeries, particularly for minimal and noninvasive surgical procedures, in the region.  Hence, such factors are driving the market growth in North America during the forecast period.

Buy Full Report Now

Key Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

AbbVie Inc: The company offers such as Botox cosmetic onabotulinumtoxin A injection under the brand Allergan Inc.

  • Bausch Health Companies Inc.
  • BTXA
  • Candela Corp.
  • Daewoong Bio Inc.
  • Eisai Co. Ltd.
  • Evolus Inc
  • FASTOX Pharma
  • Galderma SA
  • Hugel Inc
  • Huons Global
  • Ipsen Pharma
  • MedyTox Co. Ltd.
  • Merz Pharma GmbH and Co KGaA
  • NEXUS LIFECARE PVT. LTD.
  • Object Pharma Inc.
  • Revance Therapeutics Inc.
  • SciVision Biotech Inc.
  • Suneva Medical
  • USWM LLC

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. 

Market Drivers

One of the key factors driving the market growth is the increasing use of botox in dentistry. Botox is extensively used in dentistry. In addition, botox plays a critical role in managing bruxism by relaxing the jaw muscles responsible for teeth grinding. Furthermore, it Is been recommended by many dentists for patients suffering from severe cases of bruxism and temporomandibular jaw joint disorders.

Moreover, its also widely used to treat the issues of gummy smiles and release tension around the teeth and the facial muscles. In addition, botox is gaining popularity in dentistry owing to its increased use in correcting parafunctional cleaning, extracapsular myogenic temporomandibular disorder, trismus, and the headaches caused by these conditions. Hence, such factors are driving the market growth during the forecast period.

Market Trends

A key factor shaping the botox market growth is the increasing demand for preventive cosmetic treatments. The rise in demand for preventive treatments to delay the onset of wrinkles and lines, especially in younger individuals, propelled the growth of the global market. In addition, is effective in preventive treatments in cosmetic procedures in order to delay or prevent the formation of wrinkles and lines before they become more pronounced.

Moreover, this approach involves administering injections in areas prone to wrinkles in order to inhibit muscle movement and reduce the development of lines caused by repetitive facial expressions. In addition,  some individuals opt for preventive treatments in their late twenties or early thirties as a proactive measure to maintain a youthful appearance. Hence, such factors are driving the market growth during the forecast period.

 Market Challenges

Side effects associated with the use of facial aesthetic products are one of the key challenges hindering the botox market growth. Like any medical procedure, treatments, such as botox and dermal fillers,  carry a risk of potential side effects. In addition, the use of facial aesthetic products leads to temporary redness, swelling, bruising, or tenderness at the injection site.

Moreover, it also leads to allergic reactions, including itching, rash, hives, or more generalized reactions at the injection site. In addition, negative experiences or concerns about potential adverse reactions to the use of facial aesthetic products result in individuals reconsidering or avoiding undergoing treatments. Therefore, it is negatively impacting the botulinum toxin market. Hence, such factors are hindering the market growth during the forecast period.

Buy Now Full Report

 Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Customer Landscape

Segment Overview

The market report forecasts market growth by revenue at global, regional & country levels and provides a market growth analysis of the latest market trends and analysis and growth opportunities from 2018 to 2028. 

  •  Application Outlook
    • Aesthetic
    • Medical
  • End-user Outlook
    • Hospitals
    • Dermatology clinics
    • Others
  • Geography Outlook
    • North America
      • The U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Rest of Europe
    • APAC
      • China
      • India
    • Rest of the World (ROW)
      • Australia
      • Argentina
      • Brazil

Botox Market Scope

Report Coverage

Details

Page number

154

Base year

2023

Historic period

2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 9.66%

Market Growth 2024-2028

USD 4.58 billion

Market structure

Fragmented

YoY growth 2023-2024(%)

9.22

Regional analysis

North America, Europe, Asia, and the Rest of the World (ROW)

Performing market contribution

North America at 51%

Key countries

US, Mexico, Brazil, Germany, and Japan

Competitive landscape

 Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

AbbVie Inc., Bausch Health Companies Inc., BTXA, Candela Corp., Daewoong Bio Inc., Eisai Co. Ltd., Evolus Inc, FASTOX Pharma, Galderma SA, Hugel Inc, Huons Global, Ipsen Pharma, MedyTox Co. Ltd., Merz Pharma GmbH and Co KGaA, NEXUS LIFECARE PVT. LTD., Object Pharma Inc., Revance Therapeutics Inc., SciVision Biotech Inc., Suneva Medical, and USWM LLC

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Botox Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the  botox market between 2023 and 2028
  • Precise estimation of the botox market size and its contribution to the market in focus on the parent market
  • Detailed market growth and forecasting analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies position and classification
  • Accurate market forecast about upcoming market growth and trends and changes in consumer behavior
  • Growth of the market across North America, Europe, Asia, and the Rest of the World (ROW)
  • A thorough market research and growth analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive market analysis and report of factors that will challenge the growth of botox market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global botox market 2018 - 2022
      • Exhibit 18: Historic Market Size – Data Table on global botox market 2018 - 2022 ($ billion)
    • 4.2 Application Segment Analysis 2018 - 2022
      • Exhibit 19: Historic Market Size – Application Segment 2018 - 2022 ($ billion)
    • 4.3 End-user Segment Analysis 2018 - 2022
      • Exhibit 20: Historic Market Size – End-user Segment 2018 - 2022 ($ billion)
    • 4.4 Geography Segment Analysis 2018 - 2022
      • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)
    • 4.5 Country Segment Analysis 2018 - 2022
      • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by Application

    • 6.1 Market segments
      • Exhibit 30: Chart on Application - Market share 2023-2028 (%)
      • Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
    • 6.2 Comparison by Application
      • Exhibit 32: Chart on Comparison by Application
      • Exhibit 33: Data Table on Comparison by Application
    • 6.3 Aesthetic - Market size and forecast 2023-2028
      • Exhibit 34: Chart on Aesthetic - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 35: Data Table on Aesthetic - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 36: Chart on Aesthetic - Year-over-year growth 2023-2028 (%)
      • Exhibit 37: Data Table on Aesthetic - Year-over-year growth 2023-2028 (%)
    • 6.4 Medical - Market size and forecast 2023-2028
      • Exhibit 38: Chart on Medical - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 39: Data Table on Medical - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 40: Chart on Medical - Year-over-year growth 2023-2028 (%)
      • Exhibit 41: Data Table on Medical - Year-over-year growth 2023-2028 (%)
    • 6.5 Market opportunity by Application
      • Exhibit 42: Market opportunity by Application ($ billion)
      • Exhibit 43: Data Table on Market opportunity by Application ($ billion)

    7 Market Segmentation by End-user

    • 7.1 Market segments
      • Exhibit 44: Chart on End-user - Market share 2023-2028 (%)
      • Exhibit 45: Data Table on End-user - Market share 2023-2028 (%)
    • 7.2 Comparison by End-user
      • Exhibit 46: Chart on Comparison by End-user
      • Exhibit 47: Data Table on Comparison by End-user
    • 7.3 Hospitals - Market size and forecast 2023-2028
      • Exhibit 48: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
      • Exhibit 51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
    • 7.4 Dermatology clinics - Market size and forecast 2023-2028
      • Exhibit 52: Chart on Dermatology clinics - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 53: Data Table on Dermatology clinics - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 54: Chart on Dermatology clinics - Year-over-year growth 2023-2028 (%)
      • Exhibit 55: Data Table on Dermatology clinics - Year-over-year growth 2023-2028 (%)
    • 7.5 Others - Market size and forecast 2023-2028
      • Exhibit 56: Chart on Others - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 57: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 58: Chart on Others - Year-over-year growth 2023-2028 (%)
      • Exhibit 59: Data Table on Others - Year-over-year growth 2023-2028 (%)
    • 7.6 Market opportunity by End-user
      • Exhibit 60: Market opportunity by End-user ($ billion)
      • Exhibit 61: Data Table on Market opportunity by End-user ($ billion)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 63: Chart on Market share by geography 2023-2028 (%)
      • Exhibit 64: Data Table on Market share by geography 2023-2028 (%)
    • 9.2 Geographic comparison
      • Exhibit 65: Chart on Geographic comparison
      • Exhibit 66: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2023-2028
      • Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
      • Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 9.4 Europe - Market size and forecast 2023-2028
      • Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 9.5 Asia - Market size and forecast 2023-2028
      • Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 9.7 US - Market size and forecast 2023-2028
      • Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
      • Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
    • 9.8 Brazil - Market size and forecast 2023-2028
      • Exhibit 87: Chart on Brazil - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 88: Data Table on Brazil - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 89: Chart on Brazil - Year-over-year growth 2023-2028 (%)
      • Exhibit 90: Data Table on Brazil - Year-over-year growth 2023-2028 (%)
    • 9.9 Japan - Market size and forecast 2023-2028
      • Exhibit 91: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 92: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 93: Chart on Japan - Year-over-year growth 2023-2028 (%)
      • Exhibit 94: Data Table on Japan - Year-over-year growth 2023-2028 (%)
    • 9.10 Mexico - Market size and forecast 2023-2028
      • Exhibit 95: Chart on Mexico - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 96: Data Table on Mexico - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 97: Chart on Mexico - Year-over-year growth 2023-2028 (%)
      • Exhibit 98: Data Table on Mexico - Year-over-year growth 2023-2028 (%)
    • 9.11 Germany - Market size and forecast 2023-2028
      • Exhibit 99: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 100: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 101: Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Exhibit 102: Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 103: Market opportunity by geography ($ billion)
      • Exhibit 104: Data Tables on Market opportunity by geography ($ billion)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 105: Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 107: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 108: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 109: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 110: Matrix on vendor position and classification
            • 12.3 AbbVie Inc.
              • Exhibit 111: AbbVie Inc. - Overview
              • Exhibit 112: AbbVie Inc. - Product / Service
              • Exhibit 113: AbbVie Inc. - Key news
              • Exhibit 114: AbbVie Inc. - Key offerings
            • 12.4 BTXA
              • Exhibit 115: BTXA - Overview
              • Exhibit 116: BTXA - Product / Service
              • Exhibit 117: BTXA - Key offerings
            • 12.5 Daewoong Bio Inc.
              • Exhibit 118: Daewoong Bio Inc. - Overview
              • Exhibit 119: Daewoong Bio Inc. - Product / Service
              • Exhibit 120: Daewoong Bio Inc. - Key offerings
            • 12.6 Evolus Inc
              • Exhibit 121: Evolus Inc - Overview
              • Exhibit 122: Evolus Inc - Product / Service
              • Exhibit 123: Evolus Inc - Key offerings
            • 12.7 FASTOX Pharma
              • Exhibit 124: FASTOX Pharma - Overview
              • Exhibit 125: FASTOX Pharma - Product / Service
              • Exhibit 126: FASTOX Pharma - Key offerings
            • 12.8 Galderma SA
              • Exhibit 127: Galderma SA - Overview
              • Exhibit 128: Galderma SA - Product / Service
              • Exhibit 129: Galderma SA - Key news
              • Exhibit 130: Galderma SA - Key offerings
            • 12.9 Hugel Inc
              • Exhibit 131: Hugel Inc - Overview
              • Exhibit 132: Hugel Inc - Product / Service
              • Exhibit 133: Hugel Inc - Key offerings
            • 12.10 Huons Global
              • Exhibit 134: Huons Global - Overview
              • Exhibit 135: Huons Global - Product / Service
              • Exhibit 136: Huons Global - Key offerings
            • 12.11 Ipsen Pharma
              • Exhibit 137: Ipsen Pharma - Overview
              • Exhibit 138: Ipsen Pharma - Business segments
              • Exhibit 139: Ipsen Pharma - Key offerings
              • Exhibit 140: Ipsen Pharma - Segment focus
            • 12.12 MedyTox Co. Ltd.
              • Exhibit 141: MedyTox Co. Ltd. - Overview
              • Exhibit 142: MedyTox Co. Ltd. - Product / Service
              • Exhibit 143: MedyTox Co. Ltd. - Key offerings
            • 12.13 Merz Pharma GmbH and Co KGaA
              • Exhibit 144: Merz Pharma GmbH and Co KGaA - Overview
              • Exhibit 145: Merz Pharma GmbH and Co KGaA - Product / Service
              • Exhibit 146: Merz Pharma GmbH and Co KGaA - Key offerings
            • 12.14 NEXUS LIFECARE PVT. LTD.
              • Exhibit 147: NEXUS LIFECARE PVT. LTD. - Overview
              • Exhibit 148: NEXUS LIFECARE PVT. LTD. - Product / Service
              • Exhibit 149: NEXUS LIFECARE PVT. LTD. - Key offerings
            • 12.15 Object Pharma Inc.
              • Exhibit 150: Object Pharma Inc. - Overview
              • Exhibit 151: Object Pharma Inc. - Product / Service
              • Exhibit 152: Object Pharma Inc. - Key offerings
            • 12.16 Revance Therapeutics Inc.
              • Exhibit 153: Revance Therapeutics Inc. - Overview
              • Exhibit 154: Revance Therapeutics Inc. - Product / Service
              • Exhibit 155: Revance Therapeutics Inc. - Key offerings
            • 12.17 SciVision Biotech Inc.
              • Exhibit 156: SciVision Biotech Inc. - Overview
              • Exhibit 157: SciVision Biotech Inc. - Product / Service
              • Exhibit 158: SciVision Biotech Inc. - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 159: Inclusions checklist
                • Exhibit 160: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 161: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 162: Research methodology
                • Exhibit 163: Validation techniques employed for market sizing
                • Exhibit 164: Information sources
              • 13.5 List of abbreviations
                • Exhibit 165: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              botox market market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis